ENvue Medical, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$41M
↑+1033.2% +$37Mvs FY2024
Total Liabilities
$8M
↑+154.1% +$5Mvs FY2024
Equity
$33M
↑+5242.4% +$33Mvs FY2024
Cash
$4M
↑+461.7% +$3Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $41M | $4M |
| Current Assets | $7M | $3M |
| Cash | $4M | $752K |
| ST Investments | $0 | $0 |
| Receivables | $289K | $98K |
| Inventory | $2M | $2M |
| Other Current | $421K | $290K |
| Non-Current Assets | $34M | $298K |
| PPE | $119K | $9K |
| Goodwill | $29M | $0 |
| Intangibles | $4M | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $272K | $289K |
| Total Liab+Eq | $41M | $4M |
| Current Liab. | $7M | $3M |
| Accounts Payable | $719K | $47K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $175K | $15K |
| Other CL | $6M | $3M |
| Non-Current Liab. | $967K | $280K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $967K | $280K |
| Equity | $33M | $627K |
| Retained Earnings | $90M | $70M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · FEED · Comparing FY2025 vs FY2024